Copy number heterogeneity identifies ER+ breast cancer patients with adverse outcome after adjuvant endocrine therapy
Tom van den Bosch, Oscar M Rueda, Carlos Caldas, Louis Vermeulen, Daniël M Miedema
doi: https://doi.org/10.1101/2021.11.15.21266346
Tom van den Bosch
1Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
2Oncode Institute, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
MScOscar M Rueda
3MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
PhDCarlos Caldas
4Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK
5Department of Oncology, University of Cambridge, Cambridge, CB2 2QQ, UK 17
6CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0RE, UK
MDLouis Vermeulen
1Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
2Oncode Institute, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
MD PhDDaniël M Miedema
1Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
2Oncode Institute, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
PhD
Posted November 15, 2021.
Copy number heterogeneity identifies ER+ breast cancer patients with adverse outcome after adjuvant endocrine therapy
Tom van den Bosch, Oscar M Rueda, Carlos Caldas, Louis Vermeulen, Daniël M Miedema
medRxiv 2021.11.15.21266346; doi: https://doi.org/10.1101/2021.11.15.21266346
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2150)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)